Panagiotis J Vlachostergios

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 25

Top Topics

Radical Prostatectomy

Prognostic Factors

Top Venues

Current oncology (Toronto, Ont.)

Precision clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Panagiotis J Vlachostergios, Maria Papathanassiou, Maria Anagnostou, Eleni Thodou, Ioannis A Tamposis, Lampros Mitrakas, Ioannis Zachos, George K Koukoulis, Maria Samara, Vassilios Tzortzis
Mutational profile of primary clear cell renal cell carcinoma predicts recurrence and potential candidacy for adjuvant immune checkpoint inhibition. F1000Research 12 (2024)
Panagiotis J Vlachostergios, Athanasios Karathanasis, Konstantinos Dimitropoulos, Ioannis Zachos, Vassilios Tzortzis
High PSMA expression is associated with immunosuppressive tumor microenvironment in clear cell renal cell carcinoma. Precision clinical medicine 7 (2) (2024)
Panagiotis J Vlachostergios, Maria Papathanassiou, Maria Anagnostou, Eleni Thodou, Ioannis A Tamposis, Lampros Mitrakas, Ioannis Zachos, George K Koukoulis, Maria Samara, Vassilios Tzortzis
Mutational profile of primary clear cell renal cell carcinoma predicts recurrence and potential candidacy for adjuvant immune checkpoint inhibition. F1000Research 12 (2024)
Panagiotis J Vlachostergios, Athanasios Karathanasis, Konstantinos Dimitropoulos, Ioannis Zachos, Vassilios Tzortzis
High PSMA expression is associated with immunosuppressive tumor microenvironment in clear cell renal cell carcinoma. Precision clinical medicine 7 (2) (2024)
Konstantinos Evmorfopoulos, Konstantinos Marsitopoulos, Raphael Karachalios, Athanasios Karathanasis, Konstantinos Dimitropoulos, Vasileios Tzortzis, Ioannis Zachos, Panagiotis J Vlachostergios
The Immune Landscape and Immunotherapeutic Strategies in Platinum-Refractory Testicular Germ Cell Tumors. Cancers 16 (2) (2024)
Konstantinos Evmorfopoulos, Konstantinos Marsitopoulos, Raphael Karachalios, Athanasios Karathanasis, Konstantinos Dimitropoulos, Vasileios Tzortzis, Ioannis Zachos, Panagiotis J Vlachostergios
The Immune Landscape and Immunotherapeutic Strategies in Platinum-Refractory Testicular Germ Cell Tumors. Cancers 16 (2) (2024)
Konstantinos Evmorfopoulos, Georgios Chasiotis, Alexandros Barbatis, Ioannis Zachos, George N Kouvelos, Metaxia Bareka, Panagiotis J Vlachostergios, Eleni Arnaoutoglou, Vassilios Tzortzis, Miltiadis Matsagkas
Complete Vascular Replacement of the Infrarenal Inferior Vena Cava and Abdominal Aorta during Post-Chemotherapy Retroperitoneal Lymph Node Dissection for a Non-Seminomatous Germ Cell Tumor. Current oncology (Toronto, Ont.) 30 (6) (2023)
Konstantinos Evmorfopoulos, Georgios Chasiotis, Alexandros Barbatis, Ioannis Zachos, George N Kouvelos, Metaxia Bareka, Panagiotis J Vlachostergios, Eleni Arnaoutoglou, Vassilios Tzortzis, Miltiadis Matsagkas
Complete Vascular Replacement of the Infrarenal Inferior Vena Cava and Abdominal Aorta during Post-Chemotherapy Retroperitoneal Lymph Node Dissection for a Non-Seminomatous Germ Cell Tumor. Current oncology (Toronto, Ont.) 30 (6) (2023)
Konstantinos Evmorfopoulos, Georgios Chasiotis, Alexandros Barbatis, Ioannis Zachos, George N Kouvelos, Metaxia Bareka, Panagiotis J Vlachostergios, Eleni Arnaoutoglou, Vassilios Tzortzis, Miltiadis Matsagkas
Complete Vascular Replacement of the Infrarenal Inferior Vena Cava and Abdominal Aorta during Post-Chemotherapy Retroperitoneal Lymph Node Dissection for a Non-Seminomatous Germ Cell Tumor. Current oncology (Toronto, Ont.) 30 (6) (2023)
Konstantinos Evmorfopoulos, Georgios Chasiotis, Alexandros Barbatis, Ioannis Zachos, George N Kouvelos, Metaxia Bareka, Panagiotis J Vlachostergios, Eleni Arnaoutoglou, Vassilios Tzortzis, Miltiadis Matsagkas
Complete Vascular Replacement of the Infrarenal Inferior Vena Cava and Abdominal Aorta during Post-Chemotherapy Retroperitoneal Lymph Node Dissection for a Non-Seminomatous Germ Cell Tumor. Current oncology (Toronto, Ont.) 30 (6) (2023)
Konstantinos Evmorfopoulos, Lampros Mitrakas, Athanasios Karathanasis, Ioannis Zachos, Vasileios Tzortzis, Panagiotis J Vlachostergios
Upper Tract Urothelial Carcinoma: A Rare Malignancy with Distinct Immuno-Genomic Features in the Era of Precision-Based Therapies. Biomedicines 11 (7) (2023)
Maria Samara, Panagiotis J Vlachostergios, Eleni Thodou, Ioannis Zachos, Lampros Mitrakas, Konstantinos Evmorfopoulos, Vassilios Tzortzis, Antonis Giakountis
Characterization of a miRNA Signature with Enhanced Diagnostic and Prognostic Power for Patients with Bladder Carcinoma. International journal of molecular sciences 24 (22) (2023)
Panagiotis J Vlachostergios, Ioannis A Tamposis, Maria Anagnostou, Maria Papathanassiou, Lampros Mitrakas, Ioannis Zachos, Eleni Thodou, Maria Samara, Vasileios Tzortzis
Hypoxia-Inducible Factor-2-Altered Urothelial Carcinoma: Clinical and Genomic Features. Current oncology (Toronto, Ont.) 29 (11) (2022)
Neil J Shah, Vaibhav G Patel, Xiaobo Zhong, Luis Pina, Jessica E Hawley, Emily Lin, Benjamin A Gartrell, Victor Adorno Febles, David R Wise, Qian Qin, George S Mellgard, Himanshu N Joshi, Jones T Nauseef, David A Green, Panagiotis J Vlachostergios, Daniel H Kwon, Franklin Huang, Bobby Liaw, Scott T Tagawa, Philip Kantoff, Michael J Morris, William K Oh
The Impact of Androgen Deprivation Therapy on COVID-19 Illness in Men With Prostate Cancer. JNCI cancer spectrum 6 (3) (2022)
Iraklis C Mitsogiannis, Maria Mitsogianni, Vissarion Bakalis, Anna Tzortzi de Paz, Panagiotis J Vlachostergios, Vassilios Tzortzis
Health-Related Quality of Life Assessment in Daily Urologic Practice: A Survey of Greek Urologists. Research and reports in urology 14 (2022)
Christopher T Su, Emily Nizialek, Jacob E Berchuck, Panagiotis J Vlachostergios, Ryan Ashkar, Alexandra O Sokolova, Pedro C Barata, Rahul R Aggarwal, Rana R McKay, Neeraj Agarwal, Heather M McClure, Nellie N Nafissi, Alan H Bryce, A Oliver Sartor, Nicolas Sayegh, Heather H Cheng, Nabil Adra, Cora N Sternberg, Mary-Ellen Taplin, Marcin Cieslik, Ajjai S Alva, Emmanuel S Antonarakis
Differential responses to taxanes and PARP inhibitors in ATM- versus BRCA2-mutated metastatic castrate-resistant prostate cancer. The Prostate (2022)
Panagiotis J Vlachostergios, Muhammad J Niaz, Charlene Thomas, Paul J Christos, Joseph R Osborne, Daniel J A Margolis, Francesca Khani, Neil H Bander, Douglas S Scherr, Scott T Tagawa
Pilot study of the diagnostic utility of 89 Zr-df-IAB2M and 68 Ga-PSMA-11 PET imaging and multiparametric MRI in localized prostate cancer. The Prostate 82 (4) (2022)
Panagiotis J Vlachostergios, Athanasios Karathanasis, Vasileios Tzortzis
Expression of Fibroblast Activation Protein Is Enriched in Neuroendocrine Prostate Cancer and Predicts Worse Survival. Genes 13 (1) (2022)
Panagiotis J Vlachostergios, Muhammad Junaid Niaz, Myrto Skafida, Seyed Ali Mosallaie, Charlene Thomas, Paul J Christos, Joseph R Osborne, Ana M Molina, David M Nanus, Neil Harrison Bander, Scott T Tagawa
Imaging expression of prostate-specific membrane antigen and response to PSMA-targeted β-emitting radionuclide therapies in metastatic castration-resistant prostate cancer. The Prostate 81 (5) (2021)
Panagiotis J Vlachostergios, Ioannis Zachos, Vassilios Tzortzis
Biomarkers in Prostate-Specific Membrane Antigen Theranostics. Diagnostics (Basel, Switzerland) 11 (6) (2021)
Fadi Taza, Albert E Holler, Wei Fu, Hao Wang, Nabil Adra, Costantine Albany, Ryan Ashkar, Heather H Cheng, Alexandra O Sokolova, Archana M Agarwal, Adam Kessel, Alan H Bryce, Nellie Nafissi, Pedro C Barata, A Oliver Sartor, Diogo Assed Bastos, Oren Smaletz, Jacob E Berchuck, Mary-Ellen Taplin, Rahul R Aggarwal, Cora N Sternberg, Panagiotis J Vlachostergios, Ajjai S Alva, Christopher T Su, Catherine Handy Marshall, Emmanuel S Antonarakis
Differential Activity of PARP Inhibitors in BRCA1- Versus BRCA2-Altered Metastatic Castration-Resistant Prostate Cancer. JCO precision oncology 5 (2021)
Maria Samara, Maria Papathanassiou, Ioanna Farmakioti, Maria Anagnostou, Maria Satra, Lampros Mitrakas, Dimitrios Anastasiou, Georgios Chasiotis, Agamemnon Christopoulos, Athanasios Anagnostou, Anastasios Christodoulou, Alexandros Daponte, Maria Ioannou, George Koukoulis, Vassilios Tzortzis, Panagiotis J Vlachostergios
Renin-Angiotensin System Single Nucleotide Polymorphisms Are Associated with Bladder Cancer Risk. Current oncology (Toronto, Ont.) 28 (6) (2021)
Maria Samara, Maria Papathanassiou, Lampros Mitrakas, George Koukoulis, Panagiotis J Vlachostergios, Vassilios Tzortzis
DNA Repair Gene Polymorphisms and Susceptibility to Urothelial Carcinoma in a Southeastern European Population. Current oncology (Toronto, Ont.) 28 (3) (2021)
Panagiotis J Vlachostergios
The interplay of cell cycle and DNA repair gene alterations in upper tract urothelial carcinoma: predictive and prognostic implications. Precision clinical medicine 3 (3) (2020)
Vincenza Conteduca, Sheng-Yu Ku, Loredana Puca, Megan Slade, Luisa Fernandez, Judy Hess, Rohan Bareja, Panagiotis J Vlachostergios, Michael Sigouros, Juan Miguel Mosquera, Andrea Sboner, David M Nanus, Olivier Elemento, Ryan Dittamore, Scott T Tagawa, Himisha Beltran
SLFN11 Expression in Advanced Prostate Cancer and Response to Platinum-based Chemotherapy. Molecular cancer therapeutics 19 (5) (2020)